GlassScriptPhysician profile
Sean Mcintyre
NPI 1356873210
$9,238.96
in general payments reported to CMS, 2019-2025
10 companies · $1,812 in 2025
The $1,812 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,129 · 2022: $5,171 · 2023: $828 · 2024: $299 · 2025: $1,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,760 · Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,760.00 |
| Food and Beverage | $1,178.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,002.30 | 2022-2024 | Proclaim |
| Becton, Dickinson and Company | $1,760.00 | 2025 | Bd Intelliport |
| Stryker Corporation | $1,364.75 | 2022-2023 | Yukon Oct Spinal System, Niagara Lateral Access System |
| Boston Scientific Corporation | $1,319.30 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $210.29 | 2022-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $185.46 | 2023-2025 | Evoke Scs, Evoke |
| Nalu Medical, INC. | $182.59 | 2021 | |
| Next Science LLC | $103.53 | 2022 | |
| Nevro Corp. | $93.52 | 2022-2023 | Senza |
| Rayner Intraocular Lenses Limited | $17.22 | 2025 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.